References
- Curran J W. The epidemiology and prevention of the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 657–662
- Gerstoft J, Lindhardt BØ, Petersen C S, Kroon S, Ullman S, Møller S, Nielsen J O, Dickmeiss E. Antibodies to human T-cell lymphotropic virus type III in promiscuous healthy homosexual men. Relation to immunological and clinical findings. Eur J Clin Invest 1985; 15: 290–295
- Saxinger C, Gallo R C. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human T cell leukemia-lymphoma virus. Lab Invest 1983; 49: 371–377
- Center for Disease Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 1986; 35: 334–339
- Report from the WHO meeting “AIDS in Europe”, Århus 1983. Eur J Cancer Clin Oncol 1984; 20: 169–173
- Jaffe H W, Feorino P M, Darrow W W, O'Malley P M, Getcheel J P, Warfield D T, Jones B M, Echenberg D F, Francis D P, Curran J W. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men. Ann Intern Med 1985; 102: 627–628
- Melbye M, Biggar R J, Ebbesen P, Neuland C, Goedert J J, Faber V, Lorenzen I, Skinhøj P, Gallo R C, Blattner W A. Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: Development of immunologic and clinical abnormalities. Ann Intern Med 1986; 104: 496–500
- Groopman J E, Mayer K H, Sarngadharan M G, Ayotte D, Pevico A L, Finberg R, Slinski A H, Allan J D, Gallo R C. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. Ann Intern Med 1985; 102: 334–337
- Cooper D A, Gold J, May W, Penny R, Kaminsky I S, Levy J A. The spectrum of clinical and immunologic response to ARV infection. The International Conference on the Acquired Immunodeficiency Syndrome: Abstracts. American College of Physicians, Philadelphia 1985
- Goedert J J, Sarngadharan M G, Biggar R J. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet 1984; 2: 711–716
- Weiser B, Burger H, Robinson W S. Antibody to lymphadenopathy-associated virus correlates with decreased T helper: T suppressor ratios in those at increased risk for AIDS. The International Conference on the Acquired Immunodeficiency Syndrome: Abstracts. American College of Physicians, Philadelphia 1985
- Ranki A, Valle S-L, Antonen J, Suni J, Jokipii L, Jokipii A MM, Saxinger C, Krohn K. Immunosuppression in homosexual men seronegative for HTLV-III. Cancer Res 1985; 4616s–4618s, Suppl. 45
- Weber J N, Wadsworth J, Rogers L A, Moshtael O, Scott K, McManus T, Berrie E, Jeffries D J, Harris J RW, Pinching A J. Three-year prospective study of HTLV-III/LAV infection in homosexual men. Lancet 1986; 1: 1179–1182
- Polk B F, Fox R, Brookmeyer R, Kanchanaraksa S. Multicenter AIDS Cohort Study (MACS). Case-control study of incident AIDS in a cohort of seropositive gay men. Abstract, International Conference on AIDS. Paris 1986
- Blattner W A, Biggar R J, Weiss S H, Melbye M, Eyster M E, Ginzburg H M, Gallo R C, Goedert J J. 3-year AIDS incidence after HTLV-III: 5 cohorts and cofactor analyses. International Conference on AIDS, Paris 1985, Abstract
- Schwartz K, Visscher B R, Detels R, Taylor J, Nishanian P, Fahey J L. Immunological changes in lymphadenopathy virus positive and negative symptomless male homosexuals: two years of observation. Lancet 1985; 2: 831–832